Publications

Patient Preferences:

Col NF, Solomon AJ, Springmann V, Garbin C, Ionete C, Pbert L, Alvarez E, Tierman B, Hopson A, Kutz C, Berrios Morales I, Griffin C, Phillips G, Ngo L. Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals. Med Decis Making 2017, Aug 1:272989X17724434. doi: 10.1177/0272989X17724434. [Epub ahead of print]

Fortin JM, Hirota LK, Bond B, O’Connor AM, Col NF. Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak 2001;1(1):2. PMCID: 55342

Risk Communication:

Col, NF. Patient Health Communication to Improve Shared Decision Making. Chapter 17, Communicating Risks and Benefits: An Evidence-Based User’s Guide. Baruch Fischhoff, PhD, Noel T. Brewer, PhD, & Julie S. Downs, PhD, editor; US Department of Health and Human Services, Food and Drug Administration, Risk Communication Advisory Committee and consultants.

Muehlschlegel S; Quinn T; Moskowitz J; Shutter L; Goldberg R; Mazor K; Col N. What Families Need and Physicians Deliver – Contrasting Communication Preferences between Surrogate Decision-Makers and Physicians during Outcome Prognostication in Critically-Ill TBI Patients. In press, Neurocritical Care.

Fung CH, Alessi C, Truong C, Josephson K, Hays RD, Col N, Patterson ES, Martin JL. Patient-provider communication with older adults about sleep apnea diagnosis and treatment. Behavioral Sleep Medicine. Behav Sleep 2016 May 4:1-15. [Epub ahead of print].

Medical Informatics/ Personalized Decision Support

Col, NF, Correa R. Consumers and Clinical Decision Support. (book chapter) Clinical Decision Support: The Road to Adoption, 2nd Edition (editor: Robert A. Greenes). Elsevier Press. 2014.

Col, NF. New Technologies in Personalized Decision Support to Enhance Patient Choice: Applications and Challenges. Chapter in Pharmacoinformatics and Drug Discovery Technologies: Theories and Applications (editor: Tagelsir Gasmelseid) IGI Global 2012.

Clinical Decision Making

Eckman MH, Col NF, Kassirer JP. Principles of Therapeutic Decision Making. Chapter One in: Kassirer JP, Grenne HL II eds. Current Therapy in Adult Medicine, Fourth Edition. Philadelphia, B.C. Decker, Inc, 1997.

Col NF, Pauker SG. The Interpretation and Use of Clinical Information: Some Principles of Clinical Decision Making. 17^th Edition of The Merck Manual; 1999.

Col NF, Pauker SG. Clinical Decision Making. 18^th Edition of The Merck Manual of Diagnosis and Therapy; Merck Research Laboratories, Whitehouse Station, NJ, 2006.

Decision Aid Trials

Col NF, Fortin J, Ngo L, O’Connor AM, Goldberg RG. Can Computerized Decision Support Help Patients Make Complex Treatment Decisions? A Randomized Controlled Trial of an Individualized Menopause Decision Aid. Med Decis Making 2007; 27: 585-598.

Matloff ET, Moyer A, Shannon KM, Niendorf, KB, Col NF. Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision-Making. J Women’s Health, 2006;15(7):843-56.

Kaiser, Karen, Wendy Y. Cheng, Sally Jensen, Marla L. Clayman, Andrew Thappa, Frances Schwiep, Anita Chawla, Jeffrey J. Goldberger, Nananda Col, and Jeff Schein. “Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.” Current medical research and opinion 31, no. 12 (2015): 2261-2272.

Bailey RA, Pfeifer M, Shillington AC, Harshaw Q, Funnell MM, VanWingen J, Col N. Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict. BMC Health Serv Res. 2016 Jan 14; 16(1):10. Epub 2016 Jan 14

Shillington AC, Col N, Bailey RA, Jewell MA. Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone. Patient preference and adherence. 2015;9:609-617. doi:10.2147/PPA.S82555.

Framework for Personalized Risk Benefit Assessment

Matloff ET, Shannon KM, Moyer A, Col NF. Should Menopausal Women at Increased Risk for Breast Cancer Use Tamoxifen, Raloxifene, or Hormone Therapy? A Framework for Personalized Risk Assessment and Counseling. Journal of Cancer Education 2007;22 (1):10-14.

Muehlschlegel S, Shutter L, Col N, Goldberg R. Decision Aids and Shared Decision Making in Neurocritical Care: an Unmet Need in our NeuroICUs; Neurocrit Care epub 1/6/2015

Impact of Decision Aids–Cochrane Reviews

Stacey, D., Légaré, F., Col, N. F., Bennett, C. L., Barry, M. J., Eden, K. B., Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, & Trevena, L. (2014). Decision aids for people facing health treatment or screening decisions. The Cochrane Library.

Col, NF, Springmann V. (2016) Decision Aids: Do they work? Chapter in: Diefenbach M., Miller-Halegoua S., Bowen D. (eds) Handbook of Health Decision Science. Springer, New York, NY (pp 279-289).

O’Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden K, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D, TetroeJ. Patient Decision Aids for People Facing Health Screening or Treatment Decisions: A Systematic Review and Meta-analysis. Med Decis Making 2007; 27: 554-574.

O’Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009:CD001431.

Clinical Guidelines

Visvanathan K, Lippman SM, Hurley P, Temin S, Col NF et al. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Gynecol Oncol. 2009 Oct;115(1):132-4. Erratum in: Gynecol Oncol. 2010 Mar;116(3):592.

Visvanathan K, Hurley P, Bantug E, Brown P, Col N, Cuzick J, Davidson NE, De Censi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel III V, Wade JL, Lippman SM. Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Onc 2013. /JCO.2013.49.3122

NIH State-of-the-Science Panel (panel includes Col NF). National Institutes of Health State-of-the-Science Conference Statement: Management of Menopause-Related Symptoms. Ann Intern Med 2005;142(12 Part 1):1003-1013.

Ganz PA, Barry JM, Burke W, Col NF, et al. National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer. Annals Internal Medicine 2012 Vol. 156 (8):591-595.

Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Evidence-based consensus guidelines for the diagnosis and management of subclinical thyroid disease. JAMA 2004;291:228-238.

Clarifying and Expressing Values

Witteman H, Gavaruzzi T, Scherer L, Pieterse A, Fuhrel-Forbis A, Chipenda D, Kahn V, Feldman-Stewart D, Col N, Fagerlin A. Effects of Design Features of Explicit Values Clarification Methods: A Systematic Review. Medical Decision Making 2016, Jun 16. pii: 0272989X16654142. [Epub ahead of print]

Witteman HO, Scherer LD, Gavaruzzi T, Pieterse AH, Fuhrel-Forbis A, Dansokho SC, Exe N, Kahn VC, Feldman-Stewart D, Col N, Turgeon, AF, Fagerlin A. (2016). Design Features of Explicit Values Clarification Methods. A Systematic Review. Medical Decision Making, 0272989X15626397.

Fagerlin A, Pignone M, Abhjankar P, Col N, Feldman-Stewart D, Gavaruzzi P, et al. (2012). Clarifying and Expressing Values: An updated review. In Volk R & Llewellyn-Thomas H (editors). 2012 Update of the International Patient Decision Aids Standards (IPDAS) Collaboration’s Background Document. Chapter D. http://ipdas.ohri.ca/IPDAS-Chapter-D.pdf.

Fagerlin A, Pignone M, Abhjankar P, Col N, Feldman-Stewart D, Gavaruzzi P, et al. Clarifying values: an updated review. BMC Medical Informatics and Decision Making 2013;13(Supp 2).

Stalmeier P, Volk RJ, Abhyankar P, Blumenthal-Barby J, Bravo P, Buchholz A, Col N, Ozanne E, Vidal DC. (2012) Balancing the presentation of information and options. In Volk R & Llewellyn-Thomas H (editors). 2012 Update of the International Patient Decision Aids Standards (IPDAS) Collaboration’s Background Document. Chapter I. http://ipdas.ohri.ca/ IPDAS-Chapter-I.pdf.

Witteman HO, Scherer L, Gavaruzzi T, Pieterse AH, Fuhrel-Forbis A, Exe N, Kahn V, Feldman-Stewart D, Ubel PA, Col N, Fagerlin A, A systematic review of explicit values clarification exercises: 1. Decision contexts, theoretical foundations and development processes.

Chronic Pain

Pergolizzi J, Curro FA, Col N, Ghods MP, Vena D, Taylor R, Naftolin F, LeQuang J, A Multicenter Evaluation of an Opioid Patient-Provider Agreement. Postgrad Med J. 2017 May 10. pii: postgradmedj-2016-134607. doi: 10.1136/postgradmedj-2016-134607. [Epub ahead of print]

Womens’ Health

Committee on Women’s Health Research (including Col NF), Institute of Medicine. Women’s Health Research: Progress, Pitfalls, and Promise. The National Academies Press, Washington, D.C., 2010.http://books.nap.edu/openbook.php?record_id=12908&page=R1

Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417-1422.

Communicating Uncertainty

Politi MC, Han PKJ, Col NF. Communicating the uncertainty of harms and benefits of medical interventions; White Paper Series, Eisenberg Center. Med Decis Making 2007; 27: 681-695.

METHODOLOGY PAPERS

Nominal Group Technique/Hierarchical Cluster Analysis:

Time-series Analysis:

Col NF, McLaughlin T, Soumerai S, Hosmer DW, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. The impact of clinical trials on the use of medications in the setting of acute myocardial infarction. Arch Int Med 1996;156:54-60.

Decision Analysis/Markov Modeling

Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, Wong JB. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997;277:1140-1147.

Col NF, Goldberg RJ, Erban J, Fortin J, Bond BE, Chlebowski R. The survival impact of tamoxifen use for breast cancer risk reduction: Projections from a patient-specific markov model. Med Decis Making 2002; 22:1-8.

Cost Effectiveness Analysis

Orr RK, Col NF, Kuntz KM. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor positive breast cancer and clinically negative axillary nodes. Surgery 1999;126:568-576.

Latent Class Analysis

Rose JS, Chassin JL, Presson CC, Sherman SJ, Col NF. A Latent Class Typology of Young Women Smokers. Addiction 2007; 102:1310-1319.

Quantitative Epidemiology

Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417-1422.

Meadows ES, Mitchell BD, Bolge SN, Johnston JA, Col NF. Factors associated with treatment of women with osteoporosis or osteopenia from a national survey, BMC Women’s Health, 2012, 12:1. http://www.biomedcentral.com/1472-6874/12/1

Metaanalysis

Braithwaite S, Chlebowski R, Lau J, George S, Hess R, Col NF. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med, 2003;18:937-947.

Col NF, Ochs L, Springmann V, Aragaki, AK, Chlebowski RT. Metformin and Breast Cancer Risk: A Meta-analysis and Critical Literature Review. Breast Cancer Research and Treatment: Volume 135, Issue 3 (2012), 639-646.

Modeling/Simulation Techniques

Col NF, Pauker SG. Discrepancy between observational studies and randomized trials of menopausal hormone therapy: Did expectations shape experience? Ann Intern Med, 2003;139:923-929.

Focus group Analysis

Bond B, Hirota L, Fortin JM, Col NF. Women like me: Reflections on health and hormones from women treated for breast cancer. J Psychosocial Onc, 2002; 20:39-56.

Fortin JM, Hirota LK, Bond B, O’Connor AM, Col NF. Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak 2001;1(1):2.

Internet Usage Patterns

Hanauer D, Dibble E, Fortin J, Col, NF. Internet use among community college students: Implications in designing health care interventions. J Am College Health 2004;52(5):197-202.

Col NF, Fortin JM, Weber G, Braithwaite RS, Bowman SA, Kim JA, Lyons JL, Dibble E. Using the Web to promote smoking cessation and health for college-aged women. Educational Resources Information Center. Clearinghouse Number JC020766: 3/16/2002.